Association between Apolipoprotein E Polymorphism and Chronic Kidney Disease in the Korean General Population: Dong-gu Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Few studies have investigated the association between Apolipoprotein E (APOE) polymorphisms and chronic kidney disease (CKD) in the general population, and their results are inconsistent. Methods: The current study population was composed of 9,033 subjects aged ≥ 50 years who participated in the baseline survey of the Dong-gu Study, which was conducted in Korea between 2007 and 2010. APOE polymorphisms were identified by polymerase chain reaction, and the estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease equation. Results: Individuals with the APOE E2 allele had significantly lower total and low density lipoprotein cholesterol levels, those with the APOE E4 allele had lower high density lipoprotein (HDL) cholesterol levels, and those with the APOE E3 allele had lower log-triglyceride levels. Adjusting for covariates (sex, age, body mass index, smoking, systolic blood pressure, hypertension, diabetes, total cholesterol, HDL cholesterol, log-transformed triglycerides, and log-transformed albumin to creatinine ratio), mean eGFR was not significantly different among APOE alleles (E2, 69.4 mL/min/1.73 m2; E3, 69.5 mL/min/1.73 m2; E4, 69.4 ml/min/1.73 m2; P = 0.873). Additionally, the odds ratios (ORs) indicated that APOE polymorphisms were not independent risk factors for CKD (OR, 1.07; 95% confidence interval [CI], 0.91 to 1.26 for the E2 vs. E3 allele; OR, 1.01; 95% CI, 0.88 to 1.16 for the E4 vs. E3 allele). Conclusion: APOE polymorphisms were not associated with either eGFR or CKD in the general Korean population.
Abstract
Background: Few studies have investigated the association between Apolipoprotein E (APOE) polymorphisms and chronic kidney disease (CKD) in the general population, and their results are inconsistent. Methods: The current study population was composed of 9,033 subjects aged ≥ 50 years who participated in the baseline survey of the Dong-gu Study, which was conducted in Korea between 2007 and 2010. APOE polymorphisms were identified by polymerase chain reaction, and the estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease equation. Results: Individuals with the APOE E2 allele had significantly lower total and low density lipoprotein cholesterol levels, those with the APOE E4 allele had lower high density lipoprotein (HDL) cholesterol levels, and those with the APOE E3 allele had lower log-triglyceride levels. Adjusting for covariates (sex, age, body mass index, smoking, systolic blood pressure, hypertension, diabetes, total cholesterol, HDL cholesterol, log-transformed triglycerides, and log-transformed albumin to creatinine ratio), mean eGFR was not significantly different among APOE alleles (E2, 69.4 mL/min/1.73 m2; E3, 69.5 mL/min/1.73 m2; E4, 69.4 ml/min/1.73 m2; P = 0.873). Additionally, the odds ratios (ORs) indicated that APOE polymorphisms were not independent risk factors for CKD (OR, 1.07; 95% confidence interval [CI], 0.91 to 1.26 for the E2 vs. E3 allele; OR, 1.01; 95% CI, 0.88 to 1.16 for the E4 vs. E3 allele). Conclusion: APOE polymorphisms were not associated with either eGFR or CKD in the general Korean population.
참고문헌 (26)
- Eichner JE, "Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review", Am J Epidemiol, 155, pp.487~495 (2002)
- Mahley RW, "Apolipoprotein E: cholesterol transport protein with expanding role in cell biology", Science, 240, pp.622~630 (1988)
- Song Y, "Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease", Ann Intern Med, 141, pp.137~147 (2004)
- Davignon J, "Apolipoprotein E polymorphism and atherosclerosis", Arteriosclerosis, 8, pp.1~21 (1988)
- Utermann G, "Apolipoprotein E polymorphism in health and disease", Am Heart J, 113(2 Pt 2), pp.433~440 (1987)
- Liberopoulos E, "Apolipoprotein E and renal disease", Am J Kidney Dis, 43, pp.223~233 (2004)
- Araki S, "APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of casecontrol and family-based studies", Diabetes, 49, pp.2190~2195 (2000)
- Eto M, "Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients", Am J Kidney Dis, 40, pp.243~251 (2002)
- Lehtinen S, "Apolipoprotein E gene polymorphism, hypercholesterolemia and glomerular filtration rate in type 2 diabetic subjects: a 9-year follow-up study", J Biomed Sci, 10, pp.260~265 (2003)
- Roussos L, "Increased prevalence of apolipoprotein E3", E4 genotype among Swedish renal transplant recipients, 1999, pp.83, 25~30
- Shcherbak NS, "Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study", BMC Med Genet, 2, pp.8~ (2001)
- Tarnow L, "Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy", Nephrol Dial Transplant, 15, pp.625~630 (2000)
- Hixson JE, "Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI", J Lipid Res, 31, pp.545~548 (1990)
- Shin Min Ho, "The Effect of Apolipoprotein E Polymorphism on Lipid Levels in Korean Adults", Journal of Korean Medical Science, 20(3), pp.361~366 (2005), 대한의학회
- Levey AS, "Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate", Ann Intern Med, 145, pp.247~254 (2006)
- National Kidney Foundation, "K", DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, 2002, pp.39(2 Suppl 1), S1~S266
- Tan CE, "APOE polymorphism and lipid profile in three ethnic groups in the Singapore population", Atherosclerosis, 170, pp.253~260 (2003)
- Dallongeville J, "Modulation of plasma triglyceride levels by APOE phenotype: a metaanalysis", J Lipid Res, 33, pp.447~454 (1992)
- Liberopoulos EN, "Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjects", Nephrol Dial Transplant, 19, pp.2006~2012 (2004)
- Coto E, "A common APOE polymorphism is an independent risk factor for reduced glomerular filtration rate in the Spanish RENASTUR Cohort", Cardiorenal Med, 3, pp.113~119 (2013)
- Gomez-Coronado D, "Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins", Atherosclerosis, 147, pp.167~176 (1999)
- Lussier-Cacan S, "Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype", Arterioscler Thromb Vasc Biol, 22, pp.824~831 (2002)
- Muros M, "Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4", Atherosclerosis, 121, pp.13~21 (1996)
- Hsu CC, "Apolipoprotein E and progression of chronic kidney disease", JAMA, 293, pp.2892~2899 (2005)
- Seshasai RK, "Apolipoprotein E and kidney function in older adults", Clin Nephrol, 78, pp.174~180 (2012)
- Chu AY, "Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study", BMC Med Genet, 10, pp.108~ (2009)